Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huse

Showing results (851-860 of 967) with videos related to

Pageof 97
Sort By:
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between <i>ATRX</i> and <i>IDH1</i> mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastomaAntonio Omuro, Kathryn Beal, Philip Gutin, et al.
Inorganic Chemistry|June 27, 2019
Using Ultrafast X-ray Spectroscopy To Address Questions in Ligand-Field Theory: The Excited State Spin and Structure of [Fe(dcpp)<sub>2</sub>]<sup>2</sup>Alexander Britz, Wojciech Gawelda, Tadesse A Assefa, et al.
European Journal of Endocrinology|June 9, 2005
Mutation analysis of the MCHR1 gene in human obesityAnne-Kathrin Wermter, Kathrin Reichwald, Thomas Büch, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Multi-Omics Study of Ancestry in Adults with Intracranial Cancers - Glioma (MOSAIC)Melissa L Bondy, Humaira Noor, Spiridon Tsavachidis, et al.
Journal of Clinical Microbiology|May 1, 2020
Multicenter Evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for Detection and Quantification of Agents of Lower Respiratory Tract InfectionCaitlin N Murphy, Randal Fowler, Joan Miquel Balada-Llasat, et al.
Pageof 97

Showing results (851-860 of 967) with videos related to

Sort By:
Pageof 97
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between <i>ATRX</i> and <i>IDH1</i> mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma PatientsEudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastomaAntonio Omuro, Kathryn Beal, Philip Gutin, et al.
Inorganic Chemistry|June 27, 2019
Using Ultrafast X-ray Spectroscopy To Address Questions in Ligand-Field Theory: The Excited State Spin and Structure of [Fe(dcpp)<sub>2</sub>]<sup>2</sup>Alexander Britz, Wojciech Gawelda, Tadesse A Assefa, et al.
European Journal of Endocrinology|June 9, 2005
Mutation analysis of the MCHR1 gene in human obesityAnne-Kathrin Wermter, Kathrin Reichwald, Thomas Büch, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Multi-Omics Study of Ancestry in Adults with Intracranial Cancers - Glioma (MOSAIC)Melissa L Bondy, Humaira Noor, Spiridon Tsavachidis, et al.
Journal of Clinical Microbiology|May 1, 2020
Multicenter Evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for Detection and Quantification of Agents of Lower Respiratory Tract InfectionCaitlin N Murphy, Randal Fowler, Joan Miquel Balada-Llasat, et al.
Pageof 97